Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07101809 · ClinicalTrials.gov registry record · NA

Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology

A NA study, sponsored by Calyxo.

Recruiting
Registry status
NA
Development phase
150
Enrollment target

NCT07101809 is a NA study that is actively recruiting participants, run by Calyxo. The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07101809, a NA study, is actively recruiting participants, sponsored by Calyxo.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The goal of this clinical trial is to compare Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System and standard ureteroscopy (URS) with laser lithotripsy for the treatment of urolithiasis. This is a prospective, randomized (1:1), multi-center study.

Interventions

  • DEVICE Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System
  • DEVICE Standard Ureteroscopy (URS)

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2026-05
Est. Completion 2029-07
Phase NA

Sponsor

Calyxo

3 total trials

What the Registry Record Tells You About NCT07101809

The ClinicalTrials.gov registry entry for NCT07101809 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Calyxo, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System is the first listed.

NCT07101809 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07101809 about?

NCT07101809 is a clinical study titled "Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology". The goal of this clinical trial is to compare Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System and standard ureteroscopy (URS) with laser lithotripsy for the treatment of urolithiasis. This is a prospective, randomized (1:1), multi-center study.

What is the current status of trial NCT07101809?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-05. Estimated completion is 2029-07.

What interventions are being tested in trial NCT07101809?

The interventions under investigation include: Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System (DEVICE), Standard Ureteroscopy (URS) (DEVICE).

Who is sponsoring clinical trial NCT07101809?

This trial is sponsored by Calyxo, which has 3 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.